195 related articles for article (PubMed ID: 18067650)
1. Comparison of acute non-haemolytic transfusion reactions in female and male patients receiving female or male blood components.
Imoto S; Araki N; Shimada E; Saigo K; Nishimura K; Nose Y; Bouike Y; Hashimoto M; Mito H; Okazaki H
Transfus Med; 2007 Dec; 17(6):455-65. PubMed ID: 18067650
[TBL] [Abstract][Full Text] [Related]
2. Acute non-hemolytic transfusion reactions and HLA class I antibody: advantages of solid phase assay compared with conventional complement-dependent assay.
Imoto S; Kawamura K; Tokumine Y; Araki N; Akita S; Nishimura C; Inaba H; Saigo K; Mabuchi O; Okazaki H
Transfus Med; 2010 Apr; 20(2):95-103. PubMed ID: 19883399
[TBL] [Abstract][Full Text] [Related]
3. Implementation and outcomes of a transfusion-related acute lung injury surveillance programme and study of HLA/HNA alloimmunisation in blood donors.
Porretti L; Cattaneo A; Coluccio E; Mantione E; Colombo F; Mariani M; Bottelli G; Mazzucchelli S; Pappalettera M; Speranza T; Migliari M; Cambié G; Prati D; Rebulla P
Blood Transfus; 2012 Jul; 10(3):351-9. PubMed ID: 22395353
[TBL] [Abstract][Full Text] [Related]
4. A possible case of recipient anti-neutrophil and anti-human leukocyte antigen antibody-mediated fatal reverse transfusion-related acute lung injury.
Jug R; Anani W; Callum J
Transfusion; 2021 Apr; 61(4):1336-1340. PubMed ID: 33666248
[TBL] [Abstract][Full Text] [Related]
5. The Leukocyte Antibody Prevalence Study-II (LAPS-II): a retrospective cohort study of transfusion-related acute lung injury in recipients of high-plasma-volume human leukocyte antigen antibody-positive or -negative components.
Kleinman SH; Triulzi DJ; Murphy EL; Carey PM; Gottschall JL; Roback JD; Carrick D; Mathew S; Wright DJ; Cable R; Ness P; Gajic O; Hubmayr RD; Looney MR; Kakaiya RM;
Transfusion; 2011 Oct; 51(10):2078-91. PubMed ID: 21446938
[TBL] [Abstract][Full Text] [Related]
6. Predicted effect of selectively testing female donors for HLA antibodies to mitigate transfusion-related acute lung injury risk from apheresis platelets.
Eder AF; Dy BA; O'Neill EM
Transfusion; 2016 Jun; 56(6 Pt 2):1608-15. PubMed ID: 26830063
[TBL] [Abstract][Full Text] [Related]
7. Transfusion-related acute lung injury: epidemiology and a prospective analysis of etiologic factors.
Silliman CC; Boshkov LK; Mehdizadehkashi Z; Elzi DJ; Dickey WO; Podlosky L; Clarke G; Ambruso DR
Blood; 2003 Jan; 101(2):454-62. PubMed ID: 12393667
[TBL] [Abstract][Full Text] [Related]
8. The association of biologically active lipids with the development of transfusion-related acute lung injury: a retrospective study.
Silliman CC; Paterson AJ; Dickey WO; Stroneck DF; Popovsky MA; Caldwell SA; Ambruso DR
Transfusion; 1997 Jul; 37(7):719-26. PubMed ID: 9225936
[TBL] [Abstract][Full Text] [Related]
9. Blood donors implicated in transfusion-related acute lung injury with patient-specific HLA antibodies are more broadly sensitized to HLA antigens compared to other blood donors.
Saw CL; Hannach B; Petrazsko T; Nickerson P
Transfusion; 2013 Mar; 53(3):518-25. PubMed ID: 22738429
[TBL] [Abstract][Full Text] [Related]
10. Underdiagnosing of antibody-mediated transfusion-related acute lung injury: evaluation of cellular-based versus bead-based techniques.
van Stein D; Beckers EA; Peters AL; Porcelijn L; Middelburg RA; Lardy NM; van Rhenen DJ; Vlaar AP
Vox Sang; 2016 Jul; 111(1):71-8. PubMed ID: 26991993
[TBL] [Abstract][Full Text] [Related]
11. HLA class II antibodies in transfusion-related acute lung injury (TRALI). A case report.
Lydaki E; Bolonaki E; Nikoloudi E; Chalkiadakis E; Iniotaki-Theodoraki A
Transfus Apher Sci; 2005 Oct; 33(2):107-11. PubMed ID: 16115801
[TBL] [Abstract][Full Text] [Related]
12. How much residual plasma may cause TRALI?
Win N; Chapman CE; Bowles KM; Green A; Bradley S; Edmondson D; Wallis JP
Transfus Med; 2008 Oct; 18(5):276-80. PubMed ID: 18937733
[TBL] [Abstract][Full Text] [Related]
13. The prevalence of leucocyte alloantibodies in blood donors from South China.
Xia W; Ye X; Xu X; Chen D; Deng J; Chen Y; Ding H; Shao Y; Wang J; Liu J; Li H; Huang YF; Fu Y; Santoso S
Transfus Med; 2015 Dec; 25(6):385-92. PubMed ID: 26876912
[TBL] [Abstract][Full Text] [Related]
14. Specificities of leucocyte alloantibodies in transfusion-related acute lung injury and results of leucocyte antibody screening of blood donors.
Reil A; Keller-Stanislawski B; Günay S; Bux J
Vox Sang; 2008 Nov; 95(4):313-7. PubMed ID: 19138261
[TBL] [Abstract][Full Text] [Related]
15. Mechanisms of transfusion-related acute lung injury (TRALI): anti-leukocyte antibodies.
Curtis BR; McFarland JG
Crit Care Med; 2006 May; 34(5 Suppl):S118-23. PubMed ID: 16617255
[TBL] [Abstract][Full Text] [Related]
16. Screening of multiparous women to avoid transfusion-related acute lung injury: a single centre experience.
Sachs UJ; Link E; Hofmann C; Wasel W; Bein G
Transfus Med; 2008 Dec; 18(6):348-54. PubMed ID: 19140817
[TBL] [Abstract][Full Text] [Related]
17. Transfusion-related acute lung injury caused by two donors with anti-human leucocyte antigen class II antibodies: a look-back investigation.
Nicolle AL; Chapman CE; Carter V; Wallis JP
Transfus Med; 2004 Jun; 14(3):225-30. PubMed ID: 15180814
[TBL] [Abstract][Full Text] [Related]
18. A preliminary comparison of the prevalence of transfusion reactions in recipients of platelet components from donors with and without human leucocyte antigen antibodies.
Fadeyi EA; Adams S; Sheldon S; Leitman SF; Wesley R; Klein HG; Stroncek DF
Vox Sang; 2008 May; 94(4):324-8. PubMed ID: 18282262
[TBL] [Abstract][Full Text] [Related]
19. Are we underestimating reverse TRALI?
De Clippel D; Emonds MP; Compernolle V
Transfusion; 2019 Sep; 59(9):2788-2793. PubMed ID: 31241780
[TBL] [Abstract][Full Text] [Related]
20. Two cases of transfusion-related acute lung injury triggered by HLA and anti-HLA antibody reaction.
Lee JH; Kang ES; Kim DW
J Korean Med Sci; 2010 Sep; 25(9):1398-403. PubMed ID: 20808691
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
